These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 9653605)
21. Postmenopausal estrogen and progestogen therapy and the risk of uterine leiomyomas. Reed SD; Cushing-Haugen KL; Daling JR; Scholes D; Schwartz SM Menopause; 2004; 11(2):214-22. PubMed ID: 15021452 [TBL] [Abstract][Full Text] [Related]
22. Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a population-based case-control study. Tetsche MS; Jacobsen J; Nørgaard M; Baron JA; Sørensen HT Am J Gastroenterol; 2007 Feb; 102(2):275-8. PubMed ID: 17311649 [TBL] [Abstract][Full Text] [Related]
23. Estrogen therapy and risk of cardiovascular events among women with type 2 diabetes. Newton KM; LaCroix AZ; Heckbert SR; Abraham L; McCulloch D; Barlow W Diabetes Care; 2003 Oct; 26(10):2810-6. PubMed ID: 14514584 [TBL] [Abstract][Full Text] [Related]
24. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Grodstein F; Manson JE; Colditz GA; Willett WC; Speizer FE; Stampfer MJ Ann Intern Med; 2000 Dec; 133(12):933-41. PubMed ID: 11119394 [TBL] [Abstract][Full Text] [Related]
25. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study. Simon JA; Hunninghake DB; Agarwal SK; Lin F; Cauley JA; Ireland CC; Pickar JH Ann Intern Med; 2001 Oct; 135(7):493-501. PubMed ID: 11578152 [TBL] [Abstract][Full Text] [Related]
26. Is breast cancer risk the same for all progestogens? Stute P Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289 [TBL] [Abstract][Full Text] [Related]
27. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001 [TBL] [Abstract][Full Text] [Related]
28. Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. Prentice RL; Manson JE; Langer RD; Anderson GL; Pettinger M; Jackson RD; Johnson KC; Kuller LH; Lane DS; Wactawski-Wende J; Brzyski R; Allison M; Ockene J; Sarto G; Rossouw JE Am J Epidemiol; 2009 Jul; 170(1):12-23. PubMed ID: 19468079 [TBL] [Abstract][Full Text] [Related]
29. Transdermal hormone therapy and the risk of stroke and venous thrombosis. Speroff L Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199 [TBL] [Abstract][Full Text] [Related]
30. Hormone replacement therapy and myocardial infarction and stroke in postmenopausal Korean women. Baek JK; Kim HY; Kang MJ; Choi EA; Lee JK; Kim EH; Seo SK Climacteric; 2024 Aug; 27(4):406-412. PubMed ID: 38990048 [TBL] [Abstract][Full Text] [Related]
31. Risk of recurrent coronary events in relation to use and recent initiation of postmenopausal hormone therapy. Heckbert SR; Kaplan RC; Weiss NS; Psaty BM; Lin D; Furberg CD; Starr JR; Anderson GD; LaCroix AZ Arch Intern Med; 2001 Jul; 161(14):1709-13. PubMed ID: 11485503 [TBL] [Abstract][Full Text] [Related]
32. Progestogens in cardiovascular diseases: an introduction to the epidemiologic data. Mann JI Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):752-7. PubMed ID: 7065056 [TBL] [Abstract][Full Text] [Related]
33. Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction. Reiner AP; Heckbert SR; Vos HL; Ariëns RA; Lemaitre RN; Smith NL; Lumley T; Rea TD; Hindorff LA; Schellenbaum GD; Rosendaal FR; Siscovick DS; Psaty BM Blood; 2003 Jul; 102(1):25-30. PubMed ID: 12456499 [TBL] [Abstract][Full Text] [Related]
34. Postmenopausal Hormone Therapy and Risk of Stroke: Impact of the Route of Estrogen Administration and Type of Progestogen. Canonico M; Carcaillon L; Plu-Bureau G; Oger E; Singh-Manoux A; Tubert-Bitter P; Elbaz A; Scarabin PY Stroke; 2016 Jul; 47(7):1734-41. PubMed ID: 27256671 [TBL] [Abstract][Full Text] [Related]
35. Estrogen and estrogen-progestin replacement therapy and risk of postmenopausal breast cancer in Canada. Kirsh V; Kreiger N Cancer Causes Control; 2002 Aug; 13(6):583-90. PubMed ID: 12195648 [TBL] [Abstract][Full Text] [Related]
36. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Norman RJ; Flight IH; Rees MC Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730 [TBL] [Abstract][Full Text] [Related]
37. Postmenopausal hormone replacement therapy use and risk of endometrial cancer in Japanese women. Mizunuma H; Honjo H; Aso T; Urabe M; Ohta H; Kobayashi S; Sagara Y; Sanada M; Tanaka K; Dobashi K; Hayashi K; Ohama K Climacteric; 2001 Dec; 4(4):293-8. PubMed ID: 11770185 [TBL] [Abstract][Full Text] [Related]
38. Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study. Douketis JD; Julian JA; Kearon C; Anderson DR; Crowther MA; Bates SM; Barone M; Piovella F; Turpie AG; Middeldorp S; van Nguyen P; Prandoni P; Wells PS; Kovacs MJ; MacGillavry MR; Costantini L; Ginsberg JS J Thromb Haemost; 2005 May; 3(5):943-8. PubMed ID: 15869589 [TBL] [Abstract][Full Text] [Related]
39. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women. Lewis MA; Heinemann LA; Spitzer WO; MacRae KD; Bruppacher R Contraception; 1997 Sep; 56(3):129-40. PubMed ID: 9347202 [TBL] [Abstract][Full Text] [Related]
40. Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS). Simon JA; Hsia J; Cauley JA; Richards C; Harris F; Fong J; Barrett-Connor E; Hulley SB Circulation; 2001 Feb; 103(5):638-42. PubMed ID: 11156873 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]